Best Practices in NSCLC Small Specimen Collection for Clinicians
Eric H. Bernicker, MD
Christopher R. Gilbert, DO
This webinar is a recorded presentation of a live broadcast and includes the presentation, handout, and the audience QA.
Targeted therapies for advanced lung cancers continue to expand rapidly. Viewers of this presentation will get an overview of the latest developments in the management of oncogene-addicted lung cancers and the need for close collaboration between medical oncologists and pathologists to make sure that patients receive optimal therapy.
- Discuss the need for repeat biopsies upon progression so that therapies that target mechanisms of acquired resistance can be appropriately utilized.
- Explain how targeted therapies are selected for patients with advanced adenocarcinoma of the lung.
Recording Date: June 20, 2018
Duration: 1 hr
Level of Instruction: Basic
CE credit has expired for this course.
This webinar is part 2 of a five-part series aimed at breaking down barriers to NSCLC testing and treatment.
For more information on this series, please go here.
Supported by an educational grant from AstraZeneca
Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.